Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Ciprofloxacin GR: Phase II

In a double-blind Phase II study of 58 patients with UTI, Ciprofloxacin GR was

Read the full 144 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE